Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola
Condition: Ebola Virus Disease Intervention: Biological: Ad26.ZEBOV vaccine Sponsors: Universiteit Antwerpen; Johnson & Johnson; Ace Africa; Innovative Medicines Initiative; Coalition for epidemic prepardness innovations; University of Kinshasa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2019 Category: Research Source Type: clinical trials
Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC
Condition: Ebola Virus Disease Intervention: Biological: Ad26.ZEBOV, MVA-BN-Filo vaccine Sponsors: London School of Hygiene and Tropical Medicine; Epicentre; Ministère de la Santé de la RDC; Médecins Sans Frontières, France; Coalition for Epidemic Preparedness Innovations; Janssen Vaccines & Prevention B.V.; Public Health England Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 5, 2019 Category: Research Source Type: clinical trials